The G.U.T. of gut

References

• Barrow JC. Theories of everything. London: Vintage; 1990.
   Google Scholar
• Fox KC. The big bang theory. New York: John Wiley & Sons Inc.; 2002.
   Google Scholar
• Greene B. The elegant universe. London: Vintage; 2000.
   Google Scholar
• Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995; 109:1344–67.
   PubMed Web of Science ®Google Scholar
• Rath HC, Wilson KH, Sartor RB. Differential induction of colitis and gastroitis in HLA-B27 transgenic rats selectively colonized by Bacteroides vulgatus or Eschericia coli. Infect Immun 1999; 67:2966–74.
   Google Scholar
• Weiss GJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320:365–76.
   PubMed Web of Science ®Google Scholar
• Wilkinson PC. Leucocyte locomotion: determinants of locomotor capacity, chemotaxis and chemokinesis. In: Peters TJ, editor. The cell biology of inflammation in the gastrointestinal tract. Hull: Corners Publications; 1990. p. 15–27.
   Google Scholar
• Malech MI, Callin JI. Neutrophils in human disease. N Engl J Med 1987;317:687–94.
   PubMed Web of Science ®Google Scholar
• Segal AW. The electron transport chain of the microbial oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease. J Clin Invest 1989;83:1785–93.
   PubMed Web of Science ®Google Scholar
• Bywaters EGL. Historical aspects of the etiology of rheumatoid arthritis. Br J Rheumatol 1988;27 Suppl II:110–5.
   Google Scholar
• Porter R. Quacks. Fakers and charlatans in English medicine. Gloucestershire, UK: Tempus Publishing Ltd.; 2000.
   Google Scholar
• Porter R. Antiquity. In: Porter R, editor. The greatest benefit to mankind. London: Harper-Collins; 1997.
   Google Scholar
• Menzies IS. Absorption of intact oligosaccharide in health and disease. Biochem Soc Transact. 1974;2:1042–7.
   Web of Science ®Google Scholar
• Laker MF, Menzies IS. Increase in human intestinal permeability following ingestion of hypertonic solutions. J Physiol (Lond) 1977;265:881–94.
   Google Scholar
• Menzies IS, Pounder R, Heyer S, Laker MF, Bull J, Wheeler PG, et al. Abnormal intestinal permeability to sugars in villus atrophy. Lancet 1979;ii:1107–9.
   Google Scholar
• Sutherland LR, Verhoef M, Wallace JL, Rosendaahl GV, Crutcher R, Meddings JB. A simple, non-invasive marker of gastric damage: sucrose permeability. Lancet 1994; 343: 9981000.
   Web of Science ®Google Scholar
• Jenkins AP, Nukajam WS, Menzies IS, Creamer B. Simultaneous administration of lactulose and 51Cr-ethylenediaminetetraacetic acid. A test to distinguish colonic from small-intestinal permeability change. Scand J Gastroenterol 1992;27:769–73.
   Google Scholar
• Teahon K, Somasundaram S, Smith T, Menzies I, Bjarnason I. Assessing the site of increased intestinal permeability in coeliac and inflammatory bowel disease. Gut 1996;38:864–9.
   Google Scholar
• Travis S, Menzies IS. Intestinal permeability: functional assessment and significance. Clin Sci 1992;82:471–88.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Macpherson AJM, Hollander D. Intestinal permeability: An overview. Gastroenterology 1995;108:1566–81.
   Google Scholar
• Menzies IS, Crane RC. Quantitative estimation of sugars by thin-layer chromatography and scanning densitometry. Assessing intestinal absorptive capacity and permeability in vivo. In: Preedy VR, Watson RR, editors. Methods in disease: investigating the gastrointestinal tract. Oxford: Oxford University Press; 1998. p. 53–63.
   Google Scholar
• Tibble JA, Bjarnason I. Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol 2001;7:460–5.
   PubMed Web of Science ®Google Scholar
• Saverymuttu SH, Peters AM, Lavender JP, Pepys MB, Hodgson HJ, Chadwick VS. Quantitative faecal indium-111 labelled leucocyte excretion in assessment of disease activity in Crohn’s disease. Gastroenterology 1983;85:1333–9.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, DeLacey G, et al. Nonsteroidal antiinflammatory drug induced intestinal inflammation in humans. Gastroenterology 1987;93:480–9.
   PubMed Web of Science ®Google Scholar
• Tibble J, Sigthorsson G, Foster R, Scott D, Roseth A, Bjarnason I. Faecal calprotectin: a simple method for the diagnosis of NSAID-induced enteropathy. Gut 1999;45:362–6.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Williams P, Smethurst P, Peters TJ, Levi AJ. The effect of NSAIDs and prostaglandins on the permeability of the human small intestine. Gut. 1986;27:1292–7.
   Google Scholar
• Bjarnason I, Smethurst P, Fenn GC, Lee CF, Menzies IS, Levi AJ. Misoprostol reduces indomethacin induced changes in human small intestinal permeability. Dig Dis Sci 1989;34:407–11.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Smethurst P, Clarke P, Menzies IS, Levi AJ, Peters TJ. Effect of prostaglandins on indomethacin induced increased intestinal permeability in man. Scand J Gastroenterol 1989; 29 Suppl 164:97–103.
   Google Scholar
• Bjarnason I, Smethurst P, Macpherson A, Walker F, McElnay JC, Passmore AP, et al. Glucose and citrate reduce the permeability changes caused by indomethacin in humans. Gastroenterology 1992;102:1546–50.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Williams P, So A, Zanelli G, Levi AJ, Gumpel MJ, et al. Intestinal permeability and inflammation in rheumatoid arthritis; effects of non-steroidal anti-inflammatory drugs. Lancet 1984;ii:1171–4.
   Google Scholar
• Sigthorsson G, Tibble J, Hayllar J, Menzies I, Macpherson A, Moots R, et al. Intestinal permeability and inflammation in patients on NSAIDs. Gut 1998;43:506–11.
   PubMed Web of Science ®Google Scholar
• Aabakken L, Osnes M. 51Cr-ethylenediaminetetraacetic acid absorption test. Effects of naproxen, a non-steroidal, antiinflammatory drug. Scand J Gastroenterol 1990;25:917–24.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Ward K, Peters TJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet 1984;i: 17982.
   Google Scholar
• Keshavarzian A, Holmes EW, Patel M, Iber F, Fields JZ, Pethkar S. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcoholic-induced liver damage. Am J Gastroenterol 1999; 94: 200–7.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Macpherson A, Menzies IS. Intestinal permeability: the basics. In: Sutherland LR, Collins SM, Martin F, McLeod RS, Targan SR, Wallace JLK, et al, editors. Inflammatory bowel disease. Basic research, clinical implications and trends in therapy. Dordrecht: Kluwer Academic Publishers; 1994. p. 5370.
   Google Scholar
• Qvist H, Somasundaram S, Macpherson A, Menzies IS, Giercksky K, Bjarnason I. The effect of pelvic radiation on small and large intestinal absorption and permeability in man. Gastroenterology 1994;106:A430.
   Web of Science ®Google Scholar
• Carratu R, Secondulfo M, de Magistris L, Daniele B, Pignata S, D’Agostino L, et al. Assessment of small intestinal damage in patients treated with pelvic radiotherapy. Oncol Rep 1998; 5: 635–9.
   Google Scholar
• Pia de la Maza M, Gotteland M, Ramirez C, Araya M, Yudin T, Bunout D, et al. Acute nutritional and intestinal changes after pelvic radiation. J Am Coll Nutr 2001;20:637–42.
   Google Scholar
• Yeoh E, Horowitz M, Russo A, Muecke T, Robb T, Maddox A, et al. Effect of pelvic irradiation on gastrointestinal function: a prospective longitudinal study. Am J Med 1993;95:397–406.
   PubMed Web of Science ®Google Scholar
• Behrens R, Deveraux M, Hazleman B, Szaz K, Calvin J, Neale G. Investigation of auranofin-induced diarrhoea. Gut 1986;27:59–65.
   PubMed Web of Science ®Google Scholar
• Selby P, McElwain TJ, Crofts M, Lopes N, Mundy J. 51CrEDTA test for intestinal permeability. Lancet 1984;ii:39.
   Google Scholar
• Selby PJ, Lopes N, Mundy J, Crofts M, Millar JL, McElwain TJ. Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapy. Br J Cancer 1987; 55:531–3.
   PubMed Web of Science ®Google Scholar
• Fazeny-Dorner B, Veitl M, Wenzel C, Brodowicz T, Zielinski C, Muhm M, et al. Alterations in intestinal permeability following the intensified polydrug-chemotherapy IFADIC (ifosfamide, adriamycin, dacarbazine). Cancer Chemother Pharmacol 2002; 49:294–8.
   Google Scholar
• Melichar B, Kohout P, Bratova M, Solichova D, Kralickova P, Zadak Z. Intestinal permeability in patients with chemotherapy-induced stomatitis. J Cancer Res Clin Oncol 2001;127:314–8.
   PubMed Web of Science ®Google Scholar
• Daniele B, Secondulfo M, De Vivo R, Pignata S, De Magistris L, Delrio P, et al. Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer. J Clin Gastroenterol 2001;32:228–30.
   PubMed Web of Science ®Google Scholar
• Pledger JV, Pearson ADJ, Craft AW, Laker MF, Eastham EJ. Intestinal permeability during chemotherapy for childhood tumors. Eur J Pediatr 1988;147:123–7.
   Google Scholar
• Pearson ADJ, Craft AW, Pledger JV, Eastham EJ, Laker MF, Pearson CS. Small bowel function in acute lymphoblastic leukemia. Arch Dis Child 1984;59:460–5.
   PubMed Web of Science ®Google Scholar
• Budillon G, Parilli G, Capuano G, Mazzacca G, Menzies IS. The cholecystokinin effect on human intestinal permeability: influence of chenodeoxycholic and ursodeoxycholic acid administration. Digestion 1982;24:274–80.
   Google Scholar
• Erickson RA, Epsten RM. Oral chenodeoxycholic acid increases small intestinal permeability to lactulose in humans. Am J Gastroenterol 1988;83:541–4.
   PubMed Web of Science ®Google Scholar
• Maxton DG, Bjarnason I, Reynolds AP, Catt SD, Peters TJ, Menzies IS. Lactulose, 51CrEDTA, L-rhamnose and polyethylene glycol 400 as probe markers for ‘in vivo’ assessment of human intestinal permeability. Clin Sci 1986;71:71–80.
   PubMed Web of Science ®Google Scholar
• Ohri SK, Somasundaram S, Koak Y, Macpherson A, Keogh BE, Taylor KM, et al. The effect of intestinal hypoperfusion during cardiopulmonary bypass surgery on saccharide permeation and intestinal permeability in man. Gastroenterology 1994;106:318–23.
   PubMed Web of Science ®Google Scholar
• Wicks C, Somasundaram S, Bjarnason I, Menzies IS, Routley D, Potter D, et al. Comparison of enteral feeding and total parenteral nutrition after liver transplantation. Lancet 1994;344:837–40.
   PubMed Web of Science ®Google Scholar
• Oktedalen O, Lunde OC, Opstad PK, Aabakken L, Kvernebo K. Changes in the gastrointestinal mucosa after long-distance running. Scand J Gastroenterol 1992;27:270–4.
   Google Scholar
• Lambert GP, Broussard LJ, Mason BL, Mauermann WJ, Gisolfi CV. Gastrointestinal permeability during exercise: effects of aspirin and energy-containing beverages. J Appl Physiol 2001902075–80.
   Google Scholar
• Pals KL, Chang RT, Ryan AJ, Gisolfi CV. Effect of running intensity on intestinal permeability. J Appl Physiol 1997; 82: 571–6.
   PubMed Web of Science ®Google Scholar
• Twiss IM, Burggraaf J, Schoemaker RC, van Elburg RM, den Hartigh J, Cohen AF, et al. The sugar absorption test in the evaluation of the gastrointestinal intolerance to bisphosphonates: studies with oral pamidronate. Clin Pharmacol Ther 2001; 69: 431–7.
   Google Scholar
• Gabe S, Bjarnason I, Redger JM, Toloughamari Z, Johnson PJ, Barkley GR, et al. The effects of tacrolimus on mitochondrial and intestinal barrier function. Gastroenterology 1998;115:67–74.
   PubMed Web of Science ®Google Scholar
• O’Dwyer SJ, Michie HR, Ziegler TR, Revhaug A, Smith RJ, Wilmore DW. A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg 1988; 123:145964.
   Google Scholar
• Ziegler TR, Smith RJ, O’Dwyer ST, Demling RH, Wilmore DW. Increased intestinal permeability associated with infection in burn patients. Arch Surg 1988;123:1313–9.
   Google Scholar
• Goto R, Panter-Brick C, Northrop-Clewes CA, Manahdhar R, Tuladhar NR. Poor intestinal permeability in mildly stunted Nepali children: associations with weaning practices and Giardia lamblia infection. Br J Nutr 200288141–9.
   Google Scholar
• Dagci H, Ustun S, Taner MS, Ersoz G, Karacasu F, Budak S. Protozoon infections and intestinal permeability. Acta Trop 2002;81:1–5.
   PubMed Web of Science ®Google Scholar
• Alam AN, Sarker SA, Wahed MA, Khatun M, Rahaman MM. Enteric protein loss and intestinal permeability changes in children during acute shigellosis and after recovery: effect of zinc supplementation. Gut 1994;35:1707–11.
   Google Scholar
• Roy SK, Behrens RH, Haider R, Akramuzzaman SM, Mahalanabis D, Wahed MA, et al. Impact of zinc supplementation on intestinal permeability in Bangladeshi children with acute diarrhoea and persistent diarrhoea syndrome. J Pediatr Gastroenterol Nutr 1992;15:289–96.
   PubMed Web of Science ®Google Scholar
• Kordossis T, Joseph AEA, Gane JN, Bridges CE, Griffin GE. Fecal leucocytosis. indium-111 labelled autologous polymorphonuclear leucocyte abdominal scanning, and quantitative fecal indium-111 excretion in acute gastroenteritis and enteropathogen carriage. Dig Dis Sci 198833:1383–90.
   Google Scholar
• Molyneux M, Looareesuwan S, Menzies IS, Grainger SL, Phillips RE, Wattanagoon Y, et al. Reduced hepatic blood flow and intestinal malabsorption in severe falciparum malaria. Am J Trop Med Hyg 1989;40:470–6.
   PubMed Web of Science ®Google Scholar
• Wilairatana P, Meddings JB, Ho M, Vannaphan S, Looareesuwan S. Increased gastrointestinal permeability in patients with Plasmodium falciparum malaria. Clin Inf Dis 1997;24:430–5.
   Google Scholar
• Northrop CA, Lunn PG, Mainwright M, Evans J. Plasma albumin concentrations and intestinal permeability in Bangladeshi children infected with ascaris lumbricoides. Trans Royal Soc Trop Med Hyg 198781811–5.
   Google Scholar
• Northrop-Clewes CA, Rousham EK, Mascie-Taylor CN, Lunn PG. Anthelmintic treatment of rural Bangladeshi children: effect on host physiology, growth, and biochemical status. Am J Clin Nutr 2001;73:53–60.
   Google Scholar
• Raj SM, Sein KT, Anuar AK, Mustaffa BE. Effect of intestinal helminthiasis on intestinal permeability of early primary schoolchildren. Trans R Soc Trop Med Hyg 1996;90:666–9.
   PubMed Web of Science ®Google Scholar
• Noone C, Menzies IS, Banatvala JE, Scopes JW. Intestinal permeability and lactose hydrolysis in human rotaviral gastroenteritis assessed simultaneously by non-invasive differential sugar permeation. Eur J Clin Invest 1986;16:217–25.
   PubMed Web of Science ®Google Scholar
• Kukuruzovic R, Robins-Browne RM, Anstey NM, Brewster DR. Enteric pathogens, intestinal permeability and nitric oxide production in acute gastroenteritis. Pediatr Infect Dis J 2002; 21:730–9.
   PubMed Web of Science ®Google Scholar
• Isolauri E, Juntunen M, Wirens S, Vuirien P, Koivula T. Intestinal permeability changes in acute gastroenteritis: effects of clinical factors and nutritional management. J Pediatr Gastroenterol Nutr 1989;8:466–73.
   Google Scholar
• Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhoea in children. Pediatrics 1991;88:90–7.
   Google Scholar
• Jalonen T, Isolauri E, Heyman M, Crain-Denoygile AM, Sillanaukee P, Koivula T. Increased beta-lactoglobulin absorption during rotavirus enteritis in infants: relationship to sugar permeability. Pediatr Res 1991;30:290–3.
   Google Scholar
• Zhang Y, Lee B, Thompson M, Glass R, Lee RC, Figueroa D, et al. Lactulose-mannitol intestinal permeability test in children with diarrhea caused by rotavirus and cryptosporidium. Diarrhea Working Group, Peru. J Pediatr Gastroenterol Nutr2000;31:16–21.
   PubMed Web of Science ®Google Scholar
• Parrili G, Cumo R, Nardone G, Maio G, Izzo CM, Budillon G. Investigation of intestinal function during acute viral hepatitis using combined sugar load. Gut 1987;28:1439–44.
   PubMed Web of Science ®Google Scholar
• Forget P, Sodoyez-Goffaux F, Zapitelli A. Permeability of the small intestine to 51CrEDTA in children with acute gastroenteritis or eczema. J Pediatr Gastroenterol Nutr 1985;4:393–6.
   PubMed Web of Science ®Google Scholar
• Lawson GR, Nelson R, Laker MF, Ghatei MA, Bloom SR, Aynsley GA. Gut regulatory peptides and intestinal permeability in acute infantile gastroenteritis. Arch Dis Child 1992;67:272–6.
   PubMed Web of Science ®Google Scholar
• Strobel S, Byrdon WG, Ferguson A. Cellobiose/mannitol sugar permeability test complements biopsy histopathology in clinical investigations of the jejunum. Gut 1984;25:1241–6.
   Google Scholar
• Ford RPK, Menzies IS, Phillips AD, Walker-Smith JA, Turner MW. Intestinal sugar permeability: relationship to diarrhoeal disease and small bowel morphology. J Pediatr Gastroenterol Nutr 1985;4:568–74.
   Google Scholar
• Cook CG, Menzies IS. Intestinal absorption and unmediated permeation of sugars in post-infective tropical malabsorption (tropical sprue). Digestion 1986;33:109–16.
   PubMed Web of Science ®Google Scholar
• Ukabam SO, Homeda MA, Cooper BJ. Small intestinal permeability in Sudanese subjects: evidence of tropical enteropathy. Trans Roy Soc Trop Med Hyg 1986;40:204–7.
   Google Scholar
• Behrens RH, Taylor RB, Low AS, Warburton B, Pryce D. Traveller’s diarrhoea; a controlled study of its effect on chloroquine and proguanil absorption. Trans R Soc Trop Med Hyg 1994;88:86–8.
   PubMed Web of Science ®Google Scholar
• Menzies IS, Zuckerman MJ, Nukajam WS, Somasundaram S, Murphy B, Jenkins AP, et al. Geography of intestinal permeability and absorption. Gut 1999;44:483–9.
   PubMed Web of Science ®Google Scholar
• Kapembwa MS, Fleming SC, Sewankambo N, Serwadda D, Lucas S, Moody A, et al. Altered small-intestinal permeability associated with diarrhoea in human-immunodeficiency-virus-infected Caucasian and African subjects. Clin Sci 1991;81:327–34.
   Web of Science ®Google Scholar
• Ott M, Lembcke B, Staszewski S, Helm EB, Caspary WF. Intestinal permeability in patients with acquired immunodeficiency syndrome (AIDS). Klin Wochenschr 1991;69:715–21.
   Google Scholar
• Lim SG, Menzies IS, Lee CA, Johnson MA, Pounder RE. Intestinal permeability and function in patients infected with human immunodeficiency virus. Scand J Gastroenterol 1993(28: 573–80.
   Google Scholar
• Keating J, Bjarnason I, Somasundaram S, Macpherson A, Francis N, Price AB, et al. Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV-infected patients and their relation to diarrhoea. Gut 1995;37:623–9.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Sharpstone D, Francis N, Marker A, Taylor C, Barrett M, et al. Intestinal inflammation, ileal structure and function in HIV. AIDS 1996;10:1385–91.
   PubMed Web of Science ®Google Scholar
• Teahon K, Webster AD, Price AB, Weston J, Bjarnason I. Studies on the enteropathy associated with primary hypogammaglobulinaemia. Gut 1994;35:1244–9.
   Google Scholar
• Pignata C, Budillon G, Monaco G, Nani E, Cuomo R, Parrilli G, et al. Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes. Gut 1990;31:879–82.
   PubMed Web of Science ®Google Scholar
• Koltun WA, Smith RJ, Loehner D, Durdey P, Coller JA, Murray JJ, et al. Alteration in intestinal permeability after ileal pouchanal anastomosis. Dis Colon Rectum 1993;36:922–6.
   PubMed Web of Science ®Google Scholar
• Thomas P, Rihani H, Roseth A, Sigthorsson G, Price A, Nicholls RJ, et al. Assessment of ileal pouch inflammation by single-stool calprotectin assay. Dis Colon Rectum 2000;43:214–20.
   PubMed Web of Science ®Google Scholar
• Laake KO, Line PD, Aabakken L, Lotveit T, Bakka A, Eide J, et al. Assessment of mucosal inflammation and circulation in response to probiotics in patients operated with ileal pouch anastomosis for ulcerative colitis. Scand J Gastroenterol 2003; 38:409–14.
   PubMed Web of Science ®Google Scholar
• Dalzell AM, Freestone NS, Billington D, Heaf DP. Small intestinal permeability and orocaecal transit time in cystic fibrosis. Arch Dis Child 1990;65:585–8.
   PubMed Web of Science ®Google Scholar
• Leclercq-Foucart J, Forget P, Sodoyez-Gouffaux F, Zappitelli A. Intestinal permeability to 51CrEDTA in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 1986;5: 384–7.
   Google Scholar
• Leclercq-Foucart J, Forget P, Van Cutsem JL. Lactuloserhamnose intestinal permeability in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 1987;6:66–70.
   PubMed Web of Science ®Google Scholar
• Piena-Spoel M, Albers MJ, ten Kate J, Tibboel D. Intestinal permeability in newborns with necrotizing enterocolitis and controls: does the sugar absorption test provide guidelines for the time to (re-)introduce enteral nutrition? J Pediatr Surg 2001; 36:587–92.
   Google Scholar
• Dupont C, Goutail-Flaud MF. Alterations of intestinal permeability to sugars in infants following neonatal surgery. J Pediatr Gastroenterol Nutr 1990;11:66–71.
   PubMed Web of Science ®Google Scholar
• Weaver LT, Laker MF, Nelson R. Intestinal permeability in the newborn. Arch Dis Child 1984;59:236–41.
   PubMed Web of Science ®Google Scholar
• Carroll D, Corfield A, Spicer R, Cairns P. Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis. Lancet 2003;361:310–11.
   PubMed Web of Science ®Google Scholar
• Cooper BT, Ukabam SO, O’Brien IAD, Hara JPO, Corrall RJM. Intestinal permeability in diabetic diarrhoea. Diabetic Med 1987;4:49–52.
   PubMed Web of Science ®Google Scholar
• Carratu R, Secondulfo M, de Magistris L, Iafusco D, Urio A, Carbone MG, et al. Altered intestinal permeability to mannitol in diabetes mellitus type I. J Pediatr Gastroenterol Nutr 1999;28: 264–9.
   PubMed Web of Science ®Google Scholar
• Tibble J, Sigthorsson G, Foster R, Fagerhol M, Forgacs I, Bjarnason I. The use of surrogate markers of intestinal inflammation and symptom based criteria to distinguish organic from non-organic disease. Gastroenterology 2002;123:450–60.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Peters TJ. In vitro determination of intestinal permeability: demonstration of a persisting defect in patients with coeliac disease. Gut 1984;25:145–50.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Maxton D, Reynolds AP, Catt S, Peters TJ, Menzies IS. A comparison of 4 markers of intestinal permeability in control subjects and patients with coeliac disease. Scand J Gastroenterol 1994;26:630–9.
   Web of Science ®Google Scholar
• Juby LD, Rothwell J, Axon ATR. Lactulose/mannitol test. An ideal screening test for coeliac disease. Gastroenterology 1989; 96:79–85.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, O’Morain C, Levi AJ, Peters TJ. The absorption of 51Cr EDTA in inflammatory bowel disease. Gastroenterology 1983;85:318–322.
   PubMed Web of Science ®Google Scholar
• Sanderson IR, Boulton P, Menzies IS, Walker-Smith JA. Improvement of abnormal lactulose/rhamnose permeability in active Crohn’s disease of the small bowel by an elemental diet. Gut 1987;28:1073–6.
   Google Scholar
• Teahon K, Smethurst P, Macpherson AJ, Levi AJ, Menzies IS, Bjarnason I. Intestinal permeability in Crohn’s disease and its relation to disease activity and relapse following treatment with elemental diet. Eur J Gastroenterol and Hepatol 1993;5:79–84.
   Web of Science ®Google Scholar
• Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, et al. A simple method for assessing intestinal inflammation in Crohn’s disease. Gut 2000;47:506–13.
   PubMed Web of Science ®Google Scholar
• Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H. Intestinal permeability and the predictor of relapse in Crohn’s disease. Lancet 1993;341:1437–9.
   Google Scholar
• Saverymuttu SH. Clinical remission in Crohn’s disease-assessment using faecal Indium-111 granulocyte excretion. Digestion 1986;33:74–9.
   PubMed Web of Science ®Google Scholar
• Tibble J, Sigthorsson G, Fagerhol M, Bjarnason I. Surrogate markers of intestinal inflammation are predictive for relapse in patients with inflammatory bowel disease. Gastroenterology 2000;119:15–22.
   PubMed Web of Science ®Google Scholar
• Hawkey CJ. COX-2 inhibitors. Lancet 1999;353:301–14.
   Web of Science ®Google Scholar
• Bjarnason I, Hayllar J, Macpherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine. Gastroenterology 1993;104:1832–47.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Fehilly B, Smethurst P, Menzies IS, Levi AJ. The importance of local versus systemic effects of non-steroidal anti-inflammatory drugs to increase intestinal permeability in man. Gut 1991;32:275–7.
   Google Scholar
• Sigthorsson G, Crane R, Simon T, Hoover M, Quan H, Bolognese J, et al. COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin. Gut 2000;47:527–32.
   PubMed Web of Science ®Google Scholar
• Shah AA, Thjodleifsson B, Murray FE, Sigthorsson G, Oddson E, Gudjonsson H, et al. Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen. Gut 2001;48:339–46.
   PubMed Web of Science ®Google Scholar
• Morris AJ, Madhok R, Sturrock RD, Capell HA, Mackenzie JF. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal antiinflammatory drugs. Lancet 1991; 337:520.
   Google Scholar
• Bjarnason I, Zanelli G, Prouse P, Smethurst P, Levi S, Gumpel MJ, et al. Blood and protein loss via small intestinal inflammation induced by nonsteroidal anti-inflammatory drugs. Lancet 1987;2:711–4.
   PubMed Web of Science ®Google Scholar
• Hayllar J, Price AB, Smith T, Macpherson A, Gumpel MJ, Bjarnason I. Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss: effect of sulphasalazine and other disease modifying drugs. Arthr Rheum 1994;37:1146–50.
   PubMed Web of Science ®Google Scholar
• Langman MJS, Morgan L, Worrall A. Use of anti-inflammatory drugs by patients with small or large bowel perforation and haemorrhage. Br Med J 1985;290:347–9.
   Google Scholar
• Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med 1992;327:749–54.
   Google Scholar
• Bjarnason I, Macpherson A. Treatment of nonsteroidal antiinflammatory drug induced damage to the small and large intestine. In: Bayless TM, editor. Current therapy in gastroenterology and liver disease. 4th ed. St Louis, Mo., USA: Mosby; 1994. p. 295–8.
   Google Scholar
• Bjarnason I, Zanelli G, Smethurst P, Burke M, Gumpel MJ, Price AB, et al. Clinico-pathological features of nonsteroidal antiinflammatory drug induced small intestinal strictures. Gastroenterology 1988;94:1070–4.
   PubMed Web of Science ®Google Scholar
• Silverstein FE, Graham GY, Senior JR, Davies HW, Struthers BJ, Bittman RM, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. Ann Int Med 1995;123:241–9.
   PubMed Web of Science ®Google Scholar
• Bombardiner C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000;343:1520–8.
   Google Scholar
• Laine L, Bombardier C, Hawkey CJ, Davis B, Shapiro D, Brett C, et al. Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis. Gastroenterology 2002;123:1006–12.
   PubMed Web of Science ®Google Scholar
• Scarpignatio C, Bjarnason I, Bretagne J-F, de Pouvourville G, Garcia Rodriguez LA, Goldstein JL, et al. Towards a GI safer antiinflammatory therapy. Gastroenterol Int 1999;12:180–215.
   Google Scholar
• Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 1997; 112:1000–16.
   PubMed Web of Science ®Google Scholar
• Somasundaram S, Sigthorsson G, Price AB, Tavares IA, Rafi S, Mahmud T, et al. The relative importance of inhibition of cyclooxygenase and uncoupling ofoxidative phosphorylation in the gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. Alim Pharm Therap 2000;14:639–50.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Hayllar J, Smethurst P, Price AB, Menzies IS, Gumpel MJ. Metronidazole reduces inflammation and blood loss inNSAID enteropathy. Gut 1992;33:1204–8.
   PubMed Web of Science ®Google Scholar
• Haboubi NY, Montgomery RD. Small-bowel bacterial overgrowth in elderly people: clinical significance and response to treatment. Age Aging 1992;21:13–9.
   PubMed Web of Science ®Google Scholar
• Lipsky PS, Kelly PJ, James OF. Bacterial contamination of the small bowel in elderly people: is it necessarily pathological? Age Aging 1992;21:5–12.
   Google Scholar
• Saltzman JR, Kowdley KV, Pedrosa MC, Sepe T, Golner B, Perrone G, et al. Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. Gastroenterology 1994;106:615–23.
   PubMed Web of Science ®Google Scholar
• Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik K, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637–41.
   PubMed Web of Science ®Google Scholar
• Wakefield AJ, Anthony A, Murch SH, Thomson M, Montgomery SM, Davies S, et al. Enterocolitis in children with developmental disorders. Am J Gastroenterol 2000;95:2285–95.
   PubMed Web of Science ®Google Scholar
• D’Eufemia P, Celli M, Finocchiaro R, Pacifico L, Viozzi L, Zaccagnini M, et al. Abnormal intestinal permeability in children with autism. Acta Paediatr 1996;85:1076–9.
   Google Scholar
• Horvath K, Papdimitriou JC, Rabsztyn A, Drachenberg C, Tildon JT. Gastrointestinal abnormalities in children with autistic disorder. J Paediatr 1999;135:559–63.
   Google Scholar
• Anthony A, Bjarnason I, Sigthorsson G, Montgomery SM, Murch SH, Thompson M, et al. Faecal calprotectin levels correlate with acute inflammation in autistic enterocolitis. Gut 2000;46 Suppl II:A3.
   Google Scholar
• Thjodleifsson B, Davidsdottir K, Agnarsson U, Sigthorsson G, Kjeld M, et al. Effect of Pentavac and measles-mumps-rubella (MMR) vaccination on the intestine. Gut 2002;50:816–7.
   Web of Science ®Google Scholar
• Smyth RL, Croft NM, O’Hea U, Marshall TG, Ferguson A. Intestinal inflamamtion in cystic fibrosis. Arch Dis Child 2000; 82:394–9.
   Google Scholar
• De Vos M, Cuvelier C, Mielants H, Veys E, Barbier F, Elewaut A. Ileocolonoscopy in seronegative spondylarthropathy. Gastroenterology 1989;96:339–44.
   PubMed Web of Science ®Google Scholar
• De Vos M, Mielants H, Cuvelier C, Elewaut A, Veys E. Longterm evaluation of gut inflammation in patients with spondylar-thropathy. Gastroenterology 1996;110:1696–703.
   Google Scholar
• Mielants H, Veys EM, Cuvalier C, de Vos M. Ileocolonoscopic findings in seronegative spondyloarthropathies. Br J Rheumatol 1988;27 Suppl II:95–105.
   Google Scholar
• Mielants H, De Vos M, Goemaere S, Schelstraete K, Cuvelier C, Goethals K, et al. Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of antiinflammatory drugs. J Rheumatol 1991;18:394–400.
   Google Scholar
• Morris AJ, Howden CW, Robertson C, Duncan A, Torley H, Sturrock RD, et al. Increased intestinal permeability in ankylosing spondylitis—primary lesion or drug effect? Gut 1991;32:1470–2.
   PubMed Web of Science ®Google Scholar
• Vaile JH, Meddings JB, Tacyshyn BR, Russell AS, Maksymowych WP. Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives. J Rheumatol 1999;26: 128–35.
   Google Scholar
• May GR, Sutherland LR, Meddings JB. Is small intestinal permeability really increased in relatives of patients with Crohn’s disease? Gastroenterology 1993;104:1627–32.
   Google Scholar
• Martinez-Gonzales O, Cantero-Hinojosa J, Paule-Sastre P, Gomez-Magan JC, Salvatierra-Rios D. Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives. Br J Rheumatol 1994;33:644–7.
   PubMedGoogle Scholar
• Thjodleifsson B, Sigthorsson G, Cariglia N, Reynisdottir I, Gudbjartsson DF, Kristjansson K, et al. Subclinical intestinal inflammation: an inherited abnormality in Crohn’s disease relatives? Gastroenterology. 2003;124:1728–37.
   Google Scholar
• Bjarnason I, Helgason KO, Geirsson AJ, Sigthorsson G, Reynisdottir I, Gudbjartsson D, et al. Sub-clinical intestinal inflammation, HLA-B27 genotype and sacroiliac changes in first-degree relatives of patients with ankylosing spondylitis. Gastroenterology 2003;125:1598–1605.
   PubMed Web of Science ®Google Scholar
• MacQueen G, Marshall J, Perdue M, Siegel S, Bienenstock J. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science 1989;243:83–5.
   Google Scholar
• Bjarnason I, Macpherson AJS, Somasundaram S, Teahon K. Non-steroidal anti-inflammatory drugs and Crohn’s disease. In: Scholmeric J, Kruis W, Goebbell H, Hohenberger W, Gross V, editors. Inflammatory bowel diseases: pathophysiology as basis of treatment. Falk Symposium No. 67. Lancaster: Kluwer Academic Publishers; 1993. p. 208–22.
   Google Scholar
• Gusella JF, Podolski DK. Inflammatory bowel disease: is it in the genes? Gastroenterology 1998;115:1286–9.
   PubMed Web of Science ®Google Scholar
• Khoo UY, Bjarnason I, Donaghy A, Williams R, Macpherson A. Antibodies to colonic epithelial cells from the serum and colonic mucosal washings in ulcerative colitis. Gut 1995;37:63–70.
   Google Scholar
• Teahon K, Smethurst P, Levi AJ, Bjarnason I. The effect of elemental diet on intestinal permeability and inflammation in Crohn’s disease. Gastroenterology 1991;101:84–9.
   PubMed Web of Science ®Google Scholar
• Gribbin J. Science. A History 1543–2001. London: The Penguin Press; 2002. p. 392–402.
   Google Scholar